Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its programme to develop a defined bacterial product for ulcerative colitis (UC). […]
This year Probiota Americas took microbiome stakeholders to Miami to learn about new prebiotics and probiotics, about the shift of the market to internet, what next-generation analytical tools will drive the future, and much more. […]
4D pharma plc announced that the Company has received clearance from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Health Products Regulatory Authority (HPRA) to commence the Phase II study of Blautix, the […]
Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation, and Horizons Ventures, the […]
Locus Agricultural Solutions™ (Locus AG) is celebrating its one-year anniversary since initiating microbial-based soil amendment treatments focused on Florida’s struggling citrus groves. Using a unique cold chain delivery system, results confirm that the company has […]
Capstone Strategic, Inc. (Capstone) announced that Kaneka Corporation (Kaneka) of Tokyo, Japan and AB-Biotics, S.A. (ABB) of Barcelona, Spain have signed a licensing agreement which grants Kaneka the exclusive right to manufacture and offer certain […]
Phagelux, Inc. a global biotechnology company focused on the development and commercialization of novel phage and lysin antibacterial products and solutions, made multiple announcements by entities within its agricultural division. Ryan Benson, Director of US […]
4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of Live Biotherapeutic Products, today announced an agreement with a subsidiary of MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA) […]
The Microbial LLC, a company primarily focused on developing and commercializing high quality pet probiotics that benefit the animal microbiome, launched Profauna 100, a new high-count, multi-strain probiotic specifically developed to support a dog’s digestive […]
Zymo Research and CosmosID announce their partnership to provide microbiome researchers with an integrated end to end solution for accurate microbiome analysis. The partnership combines Zymo Research’s complete microbiomics product portfolio from sample collection/preservation, mock […]
The collaboration, which has launched several successful natural solutions over the last five years, has enabled both Chr. Hansen and FMC to join resources and expertise to accelerate entry into the rapidly growing biological crop […]